Islamabad: AGP Limited has announced its financial results for the half-year ending June 30, 2026, releasing a detailed account of its performance and future plans. The Board of Directors, in a meeting held on August 21, 2026, declared an interim cash dividend of Rs. 2.00 per share, equating to a 20% payout.

The company's consolidated condensed interim statement of financial position reveals an increase in total assets to Rs. 32.54 billion as of June 30, 2026, from Rs. 32.04 billion at the end of 2025. The increase is primarily attributed to a rise in non-current assets, which reached Rs. 23.50 billion, up from Rs. 23.17 billion, and current assets, which climbed to Rs. 9.04 billion from Rs. 8.87 billion.

The financial statement indicates a decrease in revenue from contracts with customers, which totaled Rs. 11.53 billion for the half-year ended June 30, 2026, compared to Rs. 12.72 billion for the same period in 2025. This represents a very large or significant move in revenue. The cost of sales also decreased to Rs. 4.67 billion from Rs. 5.34 billion, leading to a gross profit reduction to Rs. 6.85 billion from Rs. 7.38 billion.

According to information available from the Pakistan Stock Exchange (PSX), the company's equity and liabilities have been adjusted, showing a slight decrease in share capital and reserves to Rs. 16.75 billion from Rs. 17.12 billion. Non-current liabilities dropped to Rs. 5.52 billion from Rs. 6.17 billion, while current liabilities increased to Rs. 10.27 billion from Rs. 8.75 billion.

The profit before income tax and levies stood at Rs. 2.14 billion, down from Rs. 2.66 billion in the previous year, indicating a big move in profitability. The net profit for the period was reported at Rs. 1.55 billion, compared to Rs. 1.69 billion last year, with earnings per share slightly declining to Rs. 5.21 from Rs. 5.25.

AGP Limited's board did not recommend any bonus or right shares, and there were no other entitlements or price-sensitive information disclosed. The company, part of the pharmaceuticals sector, continues to navigate challenging market conditions while returning value to shareholders through dividends.